Copyright: ©Author(s) 2026.
World J Clin Oncol. Nov 24, 2026; 17(11): 127553
Published online Nov 24, 2026. doi: 10.5306/wjco.127553
Published online Nov 24, 2026. doi: 10.5306/wjco.127553
Table 1 Baseline characteristics and health-related quality of life domains of the landmark cohort (n = 232), n (%)
| Variable | Value |
| Age, median (IQR) | 67 (61-72) |
| Age < 65 years | 91 (39.2) |
| Age ≥ 65 years | 141 (60.8) |
| Sex | |
| Female | 39 (16.8) |
| Male | 193 (83.2) |
| Smoking status | |
| Never smoker | 37 (15.9) |
| Former smoker | 115 (49.6) |
| Active smoker | 79 (34.1) |
| Missing | 1 (0.4) |
| COPD | |
| No | 68 (29.3) |
| Yes | 164 (70.7) |
| Pack-years, median (IQR) | 36 (10-50) |
| < 40 | 126 (54.3) |
| ≥ 40 | 106 (45.7) |
| Type of resection | |
| Lobectomy | 187 (80.6) |
| Bilobectomy | 1 (0.4) |
| Segmentectomy | 37 (15.9) |
| Wedge Resection | 7 (3.0) |
| Histology | |
| Adenocarcinoma | 179 (77.2) |
| Squamous cell carcinoma | 33 (14.2) |
| Others | 20 (8.6) |
| Stage | |
| IA | 179 (77.2) |
| IB | 53 (22.8) |
| QLQ-C30 scores at 1 year | |
| QL2, median (IQR) | 66.7 (66.7-83.3) |
| QL2 < 66.7 | 110 (47.4) |
| QL2 ≥ 66.7 | 122 (52.6) |
| FA, median (IQR) | 0 (0-33.3) |
| FA < 22.2 | 117 (50.4) |
| FA ≥ 22.2 | 115 (49.6) |
| DY, median (IQR) | 0 (0-33.3) |
| DY = 0 | 103 (44.4) |
| DY > 0 | 129 (55.6) |
Table 2 Multivariable cause-specific Firth-penalized Cox regression model for recurrence
| Variable | Primary model HR (95%CI) | Bootstrap model median HR (95%CI) |
| Age ≥ 65 years | 6.51 (2.37-17.90) | 6.05 (3.48-15.53) |
| QL2 ≥ 66.7 | 2.50 (1.15-5.40) | 2.41 (1.47-4.30) |
| Fatigue ≥ 22.2 | 3.48 (1.66-7.27) | 3.57 (2.20-7.05) |
| Dyspnea > 0 | 0.33 (0.16-0.71) | 0.33 (0.17-0.55) |
| Model discrimination | ||
| C-index | 0.79 (0.73-0.86) | 0.79 (0.74-0.85) |
Table 3 Multivariable Fine-Gray regression model for cumulative incidence of recurrence with death as a competing event
| Variable | Primary model sHR (95%CI) | Bootstrap model median sHR (95%CI) |
| Age ≥ 65 years | 6.78 (2.37-19.39) | 6.67 (3.60-21.58) |
| QL2 ≥ 66.7 | 2.44 (1.23-4.83) | 2.42 (1.45-4.51) |
| Fatigue ≥ 22.2 | 3.47 (1.72-6.99) | 3.50 (2.12-6.97) |
| Dyspnea > 0 | 0.34 (0.17-0.69) | 0.34 (0.17-0.57) |
- Citation: Leuzzi G, Cosentino B, Sabia F, Pastorino U, Pompili C, Dai W, Guerrera F, Prisciandaro E, Lococo F, Ferrari M, Rolli L, Pardolesi A, Stanzi A, Calderoni M, Uslenghi C, Lorenzini D, Fabbri A, Proto C, Lo Russo G, Prelaj A, Marchianò A, Greco G, Solli P. Association of one-year postoperative patient-reported outcomes with recurrence and survival in stage I non-small-cell lung cancer. World J Clin Oncol 2026; 17(11): 127553
- URL: https://www.wjgnet.com/2218-4333/full/v17/i11/127553.htm
- DOI: https://dx.doi.org/10.5306/wjco.127553